Live Breaking News & Updates on லாரா பணக்காரன்

Stay updated with breaking news from லாரா பணக்காரன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Affinia Therapeutics Announces Addition of Gene Therapy Scientific and Medical Experts to Leadership Team to Advance Novel Gene Therapy Platform and Programs to the Clinic


Home / Top News / Affinia Therapeutics Announces Addition of Gene Therapy Scientific and Medical Experts to Leadership Team to Advance Novel Gene Therapy Platform and Programs to the Clinic
Affinia Therapeutics Announces Addition of Gene Therapy Scientific and Medical Experts to Leadership Team to Advance Novel Gene Therapy Platform and Programs to the Clinic
Gene editing expert Charles Albright, Ph.D., joins as chief scientific officer
Gene therapy development expert Petra Kaufmann, M.D., 
joins as chief medical officer –
WALTHAM, Mass., Feb. 17, 2021 (GLOBE NEWSWIRE) Affinia Therapeutics, an innovative gene therapy company with a proprietary platform for rationally designed adeno-associated virus (AAV) vectors and gene therapies for rare and non-rare diseases, today announced the completion of its leadership team. Collectively, the executives represent a diverse team of proven leaders in gene therapy who have successfully developed novel platforms ....

United States , North Carolina , Nordrhein Westfalen , San Francisco , Luk Vandenberghe , Laura Richman , Rob May , Charles Albright , Botond Roska , Petra Kaufmann , Paula Cobb , Faber Daeufer Itrato , Medimmune Astrazeneca , Rob Aboud , University Of California , Institute Of Molecular , Grousbeck Gene Therapy Center At Massachusetts Eye , National Institutes Of Health , Whitehead Institute , Harvard Medical School , University Of Basel , Columbia University , University Of Bonn , Office Of Rare Diseases Research , Bristol Myers Squibb , Affinia Therapeutics ,